ISSN (Print):
2212-7070
ISSN (Online):
2212-7089

Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued)

Volume 4 , Issues 2, 2017


Editorial Policies


Publication Policies

For journals and eBooks, following publication policies are applied by Bentham Science

PEER REVIEW

Bentham Science Publishers follows the double-blind peer review procedure for submissions of all manuscripts to its journals.

All submitted articles/eBook chapters are subject to an extensive peer review in consultation with members of the Journal Editorial Board and independent external referees (usually two reviewers). All manuscripts/chapters are assessed rapidly and the decision based on all the peer reviewers comment, taken by the journal’s Editor-in-Chief/eBook Editor, is then conveyed to author(s).

Copyediting and Proofs

Articles and eBook chapters must be written in good English in a clear and correct style in order to maintain uniformity throughout the text. Articles/chapters submitted are copyedited before they are published.

Reprints

High-quality, bound/unbound, print/reprints can be purchased for all published articles and book chapters.

Copyright Letter

Articles must be submitted by one of the authors of the manuscript, and should not be submitted by anyone on their behalf. The principal/corresponding author will be required to submit a Covering Letter along with the manuscript, on behalf of all the co-authors (if any). The author(s) will confirm that the manuscript (or any part of it) has not been published previously or is not under consideration for publication elsewhere. Furthermore, any illustration, structure or table that has been published elsewhere must be reported, and copyright permission for reproduction must be obtained.

APPEALS AND COMPLAINTS

Generally, the editorial decisions are not reverted. However, authors who think that their manuscript was rejected due to a misunderstanding or mistake may seek an explanation for the decision. Appeals must give sound reasoning and compelling evidence against the criticism raised in the rejection letter. A difference of opinion as to the interest, novelty, or suitability of the manuscript for the journal will not be considered as an appeal. The EIC and other relevant editors will consider the appeal and the decision thereafter taken by the journal will be deemed final. Acceptance of the manuscript is not guaranteed even if the journal agrees to reconsider the manuscript, and the reconsideration process may involve previous or new reviewers or editors and substantive revision.

Authors who wish to make a complaint should refer them to the Editor-in-Chief of the journal concerned. Complaints to the Publisher may be emailed to info@benthamscience.net

CONFLICT OF INTEREST

Financial contributions and any potential conflict of interest must be clearly acknowledged under the heading ‘Conflict of Interest’. Authors must list the source(s) of funding for the study. This should be done for each author.

PLAGIARISM PREVENTION

Plagiarism means copying or paraphrasing another writer's content, be it a text, a result or an observation, and stating it as one's own, without citing a reference to the original source. Therefore, authors should acknowledge and cite references to the work of other scientists in their manuscripts. The author should ensure that all the sources are authentic and that there is no discrepancy in the content of the manuscript.

Bentham Science is vigilant in checking and identifying the primary sources of the data within the content by using the iThenticate software to detect instances of overlapping and similarity of text in submitted manuscripts. iThenticate software verifies the content against a database of periodicals, materials on the Internet, and a comprehensive article database. The software generates a similarity report in percentage that matches the article in process and the published material. This similarity is further scrutinized for suspected plagiarism according to the publisher's Editorial Policies. The generated report comprises the overall percentage of the content reused.

The Credibility of Sources- Acknowledgments

The study of an author has to be original. If there are credible sources of the content referred to in the manuscript, the author needs to cite all of them. Authors are advised to use iThenticate before submitting a manuscript to ensure that there are no instances of plagiarism. Authors are required to provide proper consent from the individuals and contributions of other authors should be acknowledged.

Bentham Science has different editorial policies for authors who have more than one publication. Following those policies, the authors need to specify the sources of the submission in their recent work. For further details, please visit the following link of Editorial Policies for Concurrent Publication/Simultaneous Submission at https://benthamscience.com/pages/editorial-policies-main

Bentham Science strictly follows COPE guidelines to detect plagiarism. For clearer insight, authors may refer to the flowcharts provided by COPE by clicking here or visiting the COPE website.

Copyright and License Open Access Plus (Gold Open Access) in Subscription Journals and eBooks

Accepted articles can be published online for free open access view. Open access publishing provides the maximum dissemination of the article to the largest audience. All corresponding authors will be asked to indicate whether or not they wish to pay to have their paper made freely available on publication. If authors do not select the Open Access option, then their article will be published with standard subscription-based access.

Copyright (Subscription Journals and eBooks)

Editors/Authors who publish in a Bentham Journal/eBook will transfer copyright to their work to Bentham Science Publishers. Submission of a manuscript to the respective journals implies that all editors/authors have read and agreed to the content of the covering letter.

HUMAN AND ANIMAL RIGHTS

All clinical investigations should be conducted according to the Declaration of Helsinki principles. For all manuscripts reporting data from studies involving human participants, formal review and approval by an appropriate institutional review board or ethics committee are required.

For research involving animals, the authors should indicate whether the procedures followed were in accordance with the standards set forth in the eighth edition of “Guide for the Care and Use of Laboratory Animals” (grants.nih.gov/grants/olaw/guide-for-the-care-and-use-of-laboratory-animals_prepub.pdf published by the National Academy of Sciences, The National Academies Press, Washington, D.C.).

Research Involving Animals

Research work on animals should be carried out in accordance with the NC3Rs ARRIVE Guidelines. For In Vivo Experiments, please visit https://www.nc3rs.org.uk/arrive-guidelines

Authors should clearly state the name of the approval committee, highlighting that legal and ethical approvals were obtained prior to initiation of the research work carried out on animals, and that the experiments were performed in accordance with the relevant guidelines and regulations stated below.

US authors should cite compliance with the US National Research Council's "Guide for the Care and Use of Laboratory Animals"

The US Public Health Service's "Policy on Humane Care and Use of Laboratory Animals" and "Guide for the Care and Use of Laboratory Animals"

UK authors should conform to UK legislation under the Animals (Scientific Procedures) Act 1986 Amendment Regulations (SI 2012/3039).

European authors outside the UK should conform to Directive 2010/63/EU

Research in animals must adhere to ethical guidelines of the International Council for Laboratory Animal Science (ICLAS) has also published ethical guidelines.

The manuscript must clearly include a declaration of compliance with relevant guidelines (e.g. the revised Animals (Scientific Procedures) Act 1986 in the UK and Directive 2010/63/EU in Europe) and/or relevant permissions or licences obtained by the IUCN Policy Statement on Research Involving Species at Risk of Extinction and the Convention on the Trade in Endangered Species of Wild Fauna and Flora.

RESEARCH INVOLVING PLANTS

All experimental research on plants (either cultivated or wild), should comply with international guidelines. The manuscript should include a declaration of compliance of field studies with relevant guidelines and/or relevant permissions or licenses obtained by the IUCN Policy Statement on Research Involving Species at Risk of Extinction and the Convention on the Trade in Endangered Species of Wild Fauna and Flora.

Patient Consent

Compliance with the guidelines of the International Committee of Medical Journal Editors www.icmje.org) is recommended, in accordance with the patient’s consent for research or participation in a study as per the applicable laws and regulations regarding the privacy and/or security of personal information, including, but not limited to, the Health Insurance Portability and Accountability Act of 1996 ("HIPAA") and other U.S. federal and state laws relating to confidentiality and security of personally distinguishable evidence, the General Data Protection Regulation (GDPR) (EU) 2016/679 and member state implementing legislation, Canada's Personal Information Protection and Electronic Documents Act, India's Information Technology Act and related Privacy Rules, (together "Data Protection and Privacy Laws").

It is the responsibility of the author to ensure that:

Patients' names, initials, or hospital numbers are not mentioned anywhere in the manuscript (including figures).

Authors are responsible for obtaining the patient consent-to-disclose forms for all recognizable patients in photographs, videos, or other information that may be published in the Journal, in derivative works, or on the journal’s website and for providing the manuscript to the recognizable patient for review before submission.

The consent-to-disclose form should indicate specific use (publication in the medical literature in print and online, with the understanding that patients and the public will have access) of the patient's information and any images in figures or videos, and must contain the patient's signature or that of a legal guardian along with a statement that the patient or legal guardian has been offered the opportunity to review the identifying materials and the accompanying manuscript.

If the manuscript has an individuals’ data, such as personal details, audio-video material, etc., consent should be obtained from that individual. In case of children, consent should be obtained from the parent or the legal guardian.

A specific declaration of such approval and consent-to-disclose form must be made in the copyright letter and in a stand-alone paragraph at the end of the article especially in the case of human studies where inclusion of a statement regarding obtaining the written informed consent from each subject or subject's guardian is a must. The original should be retained by the guarantor or the corresponding author. Editors may request to provide the original forms by fax or email.

All such case reports require by a proper consent being obtained prior to publishing

Editors may request that authors provide documentation of the formal review and recommendation from the institutional review board or ethics committee responsible for oversight of the study. The editors reserve the right to reject manuscripts that do not comply with the above-mentioned requirements. The author will be held responsible for false statements or failure to fulfill the above-mentioned requirements.

Non-Identifiable Images

Anonymous images, that do not identify the individual directly or indirectly, such as through any identifying marks or text, do not require formal consent, for example, X-rays, ultrasound images, pathology slides or laparoscopic images.

In case consent is not obtained, concealing the identity through eye bars or blurring the face would not be acceptable.

Conclusion

Author(s) and Reviewers must be informed in case of misinterpretation or mishandling of International Acceptable Standards

A strict notice should be sent to the author and reviewer to avoid future unethical misconduct

An Editorial on the reported misconduct should be published or official notice of unethical behavior should be posted on the website

Official letter about this misconduct should be issued to the Head of Departments, Funding Agencies of the accused author and the reviewer, as well as Abstracting & Indexing Agencies

Where required, retraction and withdrawal of publication may be undertaken from the Publisher’s journal in discussion with the Head of the Department of the author or reviewer, and other higher authorities should be informed

The Publisher may impose restrictions for some period on future publications from the accused author in the journals

ERRATA OR A CORRIGENDA AND CORRECTIONS IN PUBLISHED ARTICLES Authors and readers are encouraged to notify the Editor-in-Chief if they discover errors in published content, authors’ names and affiliations or if they have reasons for concern over the legitimacy of a publication. In such cases, Bentham OPEN will publish an ERRATUM or a CORRIGENDUM, in consultation with the Editor-in-Chief and authors of the article, and/or replace or retract the article. ARTICLE WITHDRAWAL

Articles in Press (articles that have been accepted for publication or published as E-pub Ahead of Schedule but which have not been formally published with volume/issue/page information) that include errors, or are determined to violate the publishing ethics guidelines such as multiple submission, fake claims of authorship, plagiarism, fraudulent use of data or the like, may be “Withdrawn” from the journal. Withdrawal means that the article files are removed and replaced with a PDF stating that the article has been withdrawn from the journal in accordance with BSP Editorial Policies.

ARTICLE RETRACTION

Published articles (with volume/issue/page information) which may contain infringements of professional ethical codes, such as multiple submission, bogus claims of authorship, plagiarism, fraudulent use of data or the like are retracted.

A retraction note titled “Retraction: [article title]” signed by the authors and/or the Editor-in-Chief is published in the paginated part of a subsequent issue of the journal and listed in the contents list.

In the electronic version, a link is made to the original article.

The online article is preceded by a screen containing the retraction note. It is to this screen that the link resolves; the reader can then proceed to the article itself.

The original article is retained unchanged with a watermark on the PDF indicating on each page that it is “retracted”

The HTML version of the document is removed.

CONCURRENT PUBLICATION/SIMULTANEOUS SUBMISSION

It is a condition of publication that manuscripts submitted to the Bentham journal have not been published and will not be simultaneously submitted or published elsewhere. Plagiarism is strictly forbidden, and by submitting the article for publication the authors agree that the publishers have the legal right to take appropriate action against the authors, if plagiarism or fabricated information is discovered.

Abstracts and posters at conferences, results presented at meetings (for example, to inform investigators or participants about findings), results databases (data without interpretation, discussion, context or conclusions in the form of tables and text to describe data/information where this is not easily presented in tabular form) are not considered to be prior publication.

Authors who wish to publish translations of the articles that has been published elsewhere should ensure that they have appropriate permission(s), should indicate clearly that the material has been translated and re-published, and should indicate clearly the original source of the material. The Editor-in-Chief may request copies of related publications if they are concerned about overlap and possible redundancy.

PERMISSION FOR REPRODUCTION:

Bentham Science has collaborated with the Copyright Clearance Center to meet our customer’s licensing, besides rights & permission needs.

The Copyright Clearance Center’s RightsLink® service makes it faster and easier to secure permission from Bentham Science journal titles. Simply visit Journals by Title and locate the desired content. Then go to the article’s abstract and click on “Rights and Permissions” to open the RightsLink’s page. If you are unable to locate the content you wish to use or are unable to secure the rights you are seeking, please e-mail us at permissions@benthamscience.net

Published/reproduced material should not be included unless written permission has been obtained from the copyright holder, which should be forwarded to the Editorial Office in case of acceptance of the article for publication.

Open Access Articles

Articles are licensed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0) (https://creativecommons.org/licenses/by/4.0/legalcode), which permits unrestricted distribution and reproduction in any medium, as long as the work is properly credited/attributed. For more details, please visit Open Access Policy

DISCLAIIMER

Responsibility for the content published by Bentham Science Publishers (BSP) in any of its journals, including any opinions expressed therein, rests exclusively with the author(s) of such content. To the maximum extent permitted by applicable law, BSP (on its own behalf, and on behalf of its staff and members of its editorial board) disclaims responsibility for any and all injury and/or damage (whether financial or otherwise) to persons or property, resulting directly or indirectly from any ideas, methods, instructions or products (including errors in the same) referred to in the content of any of BSP’s journals. Any dispute arising, including any claim, shall be governed exclusively by the laws of the United Arab Emirates, as applied in the Emirate of Sharjah.

© 2024 Bentham Science Publishers | Privacy Policy